Both in Ophthalmic Goods
National Vision Holdings vs RxSight
Over the past year EYE returned −35.1% and RXST returned −44.7%; their daily moves had a correlation of 0.21.
EYE −35.1% RXST −44.7%Growth of $1, one year, split-adjusted
| Metric | EYE | RXST |
|---|---|---|
| Price | $17.13 | $4.80 |
| Market cap | $1.35B | $199.6M |
| Today | +3.25% | −1.44% |
| 1 month | +4.5% | +2.6% |
| 6 months | −21.8% | −35.0% |
| Year to date | −33.7% | −53.9% |
| 1 year | −34.8% | −44.1% |
| Revenue growth (YoY) | +2.5% | +0.3% |
| Gross margin | 58.2% | 76.7% |
| Net margin | 2.5% | −35.9% |
| P/E (TTM) | 26.9× | — |
| Price / sales | 0.7× | 1.6× |
| Net cash | -$201.7M | $208.8M |
| Dividend yield | — | — |
| Volatility (60d) | 52.1% | 50.3% |
| Short % of float | 20.4% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).